The global market for medical robotics and computer-assisted surgical technologies is projected to reach $4.6 billion in 2019, according to a report from BCC Research.
Here are five things to know about the market:
1. The market is expected to s expected to grow to $4.6 billion, with a five-year compound annual growth rate of 7 percent. Factors affecting market growth include a steadily aging global population and increasing demand for minimally invasive surgical procedures such as heart and orthopedic surgery.
2. The United States is expected to account for nearly 75 percent of the market by 2019; however, the fastest-growing market is the Asia-Pacific region, which will grow at a compound annual growth rate of 13.4 percent.
3. Surgical robots accounting for about three-quarters of the global market for medical robotics and computer-assisted surgical technologies, with endoscopic surgery being the most important application worldwide. Other types of medical robot and computer-assisted surgical applications are gaining in importance as well. Orthopedic applications are expected to more than triple their market share between 2013 and 2019.
4. Leading players in the medical robotics and computer-assisted surgical technologies market include Mazor Robotics and Stryker. Mazor Robotics is the developer of the Renaissance surgical guidance system, which has been used in the placement of over 45,000 implants worldwide. The company recorded a significant net loss of $20.5 million for the year ended Dec. 31, 2013. However, it sold 23 systems in 2013.
In October 2012, Stryker launched a computer-assisted surgery system, Stryker ADAPT for the Gamma3 Locking Nail System, for hip surgery. The system automatically identifies the Gamma3 Locking Nail relative to the patient's anatomy and provides computer guidance to assist the surgeon with implant alignment, lag screw length and lag screw positioning.
5. Robotic guidance during spine surgery has been proven safe and effective. An article published recently in the Journal of Neurosurgery: Spine found that 83.6 percent of the robotically-placed screws had a perfect trajectory in 95 patients with degenerative disease who underwent elective lumbar instrumentation.
Earlier this year, a study published in Spine showed that radiation exposure of the surgeon and the operating room staff in a series of robot-assisted vertebral body augmentation was 74 percent lower than published results on fluoroscopy guidance and approximately 50 percent lower than the literature on navigated augmentation.
More Articles on Devices:
5 Key Results: LDR's Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018